|
Pioneer Raises $15 Million for NuBac IDE Study
By Walter Eisner (posted January 5, 2009)
Pioneer Surgical is getting a helping hand from the State of Michigan. The Upper Peninsula device company has raised $15 million in new investments to pay for an FDA pivotal study for its NuBac nucleus replacement device.
FDA Holiday Present for ReGen Biologics
By Walter Eisner (posted January 5, 2009)
Merry Christmas, Happy Hanukah and Happy New Year ReGen Biologics shareholders. We’ll also throw in a Happy Kwanzaa and Solstice for good measure. ReGen needs all the friends it can get.
Medtronic’s Excellent China Spine Adventure
By Walter Eisner (posted December 19, 2008)
Medtronic's toe in China just got a little wetter. The company announced on December 18th that it had completed its equity investment in China's Weigao Group Medical Polymer Company Limited.
Centinel Spine Continues Transformation
By Walter Eisner (posted December 18, 2008)
Centinel Spine, the descendant of Raymedica, continues to morph into its new form. On December 16, Centinel Spine announced that the company was on track to see increased revenue by early 2009 due to having secured exclusive distribution rights to market STALIF TT™ (Stand Alone Lumbar Interbody Fusion) products for the entire globe.
Orthofix Defends Itself and Dumps Debt
By Walter Eisner (posted December 18, 2008)
As Orthofix fights off a hedge fund threatening to board its corporate ship, the company announced that it was going to dump some ballast by paying off some debt early.
Gang of Four Named To Challenge Orthofix Directors
By Walter Eisner (posted December 15, 2008)
We recently reported that hedge fund Ramius LLC was threatening to call a special meeting of Orthofix shareholders. At the meeting, if called, they would vote to throw four of ten current Orthofix board members overboard and replace them with Ramius' own slate of candidates.
Veteran-Friendly Carbondale Prosthetic’s Firm Wins Award
By Robin Young (posted December 15, 2008)
U.S. military veterans from throughout southern Illinois have been making their way down Highway 51 to get to the winner of The Freedom Award for excellence in treating U.S. military veterans.
Direct Hit: BioMimetic Achieves Enrollment Target
By Elizabeth Hofheinz (posted December 15, 2008)
BioMimetic Therapeutics, Inc. has announced that the company has completed the enrollment of 396 patients in its North American pivotal clinical study for its lead orthopedic product candidate Augment™ Bone Graft. The study is designed to assess the safety and efficacy of Augment for the treatment of hindfoot and ankle fusions as compared to autograft.
Dodging Bullets at ArthroCare
By Robin Young (posted December 15, 2008)
NASDAQ was going to take this $350 million (revenue), $420 million market value and $40 million annual earnings company off of its listing of stocks. Being “delisted” means that investors will have a harder time buying and selling the common stock of ArthroCare.
 The Cheapest Orthopedic Company Ever
By Robin Young (posted December 9, 2008)
The market for equities has become a flea market, a thrift shop, a place where cheapskate buyers pick through piles of discarded, broken and ignored pieces of companies. Like Osteotech—the cheapest orthopedic company ever.
“Pirates” of the Caribbean Attack Orthofix
By Walter Eisner (posted December 9, 2008)
Caribbean-based Orthofix International is under threat of being boarded by hedge fund pirates who want it to toss Blackstone Medical overboard. Read about this swashbuckling drama here.
OtisMed Gets ISO 13485 Certification
By Elizabeth Hofheinz (posted December 8, 2008)
OtisMed Corp. has announced that it has cleared the ISO 13485:2003 certification hurdle for its quality management system by one of the world’s largest notified bodies, BSI Management Systems.
Stryker Offers Tritanium™ System to Patients and Dividend to Shareholders
By Walter Eisner (posted December 5, 2008)
Stryker is now making its Tritanium Primary Acetabular System widely available. On December 3, the company said that its system, was previously only available on a limited basis for revision cases due to its cost.
ReGen Biologics’ Reverse Stock Split
By Walter Eisner (posted December 5, 2008)
A couple of weeks after receiving a favorable recommendation from the FDA's Ortho panel for its collagen scaffold technology, ReGen Biologics announced on December 1 that it had executed a 1-for-20 reverse split of its common stock.
Biospace med’s EOS Tops Computed Radiography
By Elizabeth Hofheinz (posted December 3, 2008)
Biospace med is announcing positive results from a clinical study of its FDA-cleared ‘EOS’ 3D X-ray orthopedic imaging system. Conducted by a Montreal-based hospital, the study showed that the EOS ultra-low-dose orthopedic imaging system makes possible “better image quality” than CR (computed radiography) imaging while using nearly 10 times less radiation.
OrthoPediatrics Recognized by Fibrous Dysplasia Foundation
By Elizabeth Hofheinz (posted November 23, 2008)
The Fibrous Dysplasia Foundation (FDF) has presented the 2008 Constellation Award to OrthoPediatrics, Corp. (OP) of Warsaw, Indiana. for their efforts to understand and meet the needs of children with orthopedic problems.
Spine Tingling: New Contracts for Big Players
By Elizabeth Hofheinz (posted November 20, 2008)
Novation, a healthcare contracting services company of VHA Inc., University HealthSystem Consortium (UHC) and Provista, LLC, is announcing that it has awarded new spine contracts to some major players, namely, Biomet, DePuy, Medtronic, Stryker, and Synthes.
Deloitte: BioMimetic on Technology Fast 500
By Elizabeth Hofheinz (posted November 16, 2008)
Burnin’ up the balance sheets…BioMimetic Therapeutics, Inc., a company focused on developing and commercializing bio-active recombinant protein-device combination products, is announcing that it ranked number 181 on Deloitte’s 2008 Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, and life sciences companies in North America.
CE Mark for Amedica's Ceramic Implant
By Walter Eisner (posted November 14, 2008)
Amedica's Valeo™ family of ceramic spinal intervertebral spacers, utilizing silicon nitride ceramic technology, has received a CE (Conformité Européene) Mark.
Blackstone Loss, Ortho Growth Highlight Orthofix Quarter
By Walter Eisner (posted November 12, 2008)
Orthofix reported a massive loss of $237 million for the third quarter due to a "hefty impairment charge" for its Blackstone unit. In a November 6 press release, excluding the inventory and reserve charge for Blackstone, the company said it earned $5.8 million for the quarter.
|
Orthopedic Decisions Start Here.
